首頁
1
衛教資訊
2
藥物測試研究
3
NF國際醫療測試研究 - 24
http://www.nf.org.tw/custom_32017.html NF國際醫療測試研究 - 2 NF國際醫療測試研究 - 2 症狀 醫療測試方法  測試期別 Neurofibroma, Plexiform Drug: tipifarnib Phase 2 Neurofibromatosis Type I  Other: placebo  Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN  Drug: PD-0325901 Phase 2 Neurofibromatosis Type 1 Drug: RAD001: Everolimus Phase 2 Plexiform Neurofibroma  Tuberous Sclerosis Drug: Skincerity Phase 1 Neurofibromatoses Drug: Skincerity plus sirolimus/rapamycin Angiofibroma Drug: Skinercity plus sirolimus/rapamycin  Neurofibroma    Neurofibromatosis Type 1 (NF1)  Drug: Cholecalciferol  Phase 2 Neurofibromatosis Type 1 Drug: Cediranib Maleate  Phase 2 Plexiform Neurofibroma Spinal Cord Neurofibroma  Neurofibromatosis Type 1 Other: Laboratory Biomarker Analysis Phase 2 Plexiform Neurofibroma  Other: Pharmacological Study   Other: Quality-of-Life Assessment   Drug: Selumetinib  在本網頁提供的資料僅供參考,並非對醫療上的建議,也不構成上市臨床活動的認可。以上是美國和歐洲的資訊來源所整理的醫療試驗。 李銘仁整理 2015-12-07  

號外號外~恭喜!!優秀的病友學子們得到罕病協會的【優秀獎助學金】

首頁 衛教資訊 > 藥物測試研究 > NF國際醫療測試研究 - 2

症狀 醫療測試方法  測試期別
Neurofibroma, Plexiform Drug: tipifarnib Phase 2
Neurofibromatosis Type I  Other: placebo 
Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN  Drug: PD-0325901 Phase 2
Neurofibromatosis Type 1 Drug: RAD001: Everolimus Phase 2
Plexiform Neurofibroma 
Tuberous Sclerosis Drug: Skincerity Phase 1
Neurofibromatoses Drug: Skincerity plus sirolimus/rapamycin
Angiofibroma Drug: Skinercity plus sirolimus/rapamycin 
Neurofibroma   
Neurofibromatosis Type 1 (NF1)  Drug: Cholecalciferol  Phase 2
Neurofibromatosis Type 1 Drug: Cediranib Maleate  Phase 2
Plexiform Neurofibroma
Spinal Cord Neurofibroma 
Neurofibromatosis Type 1 Other: Laboratory Biomarker Analysis Phase 2
Plexiform Neurofibroma  Other: Pharmacological Study
  Other: Quality-of-Life Assessment
  Drug: Selumetinib 

網頁提供的資料僅供參考,並非醫療上的建議,也不構成上市臨床活動的認可。以美國和歐洲的資訊來源所整理的醫療試驗

李銘仁整理 2015-12-07